Just-in-Time Mentor Meeting: Careers in Finance
July 8th, 2 – 3:30 pm
The due date for applications has been extended from July 26th to July 1st, 5 pm.
Just-in-Time Mentor Meetings will provide an opportunity for late-stage graduate students and postdocs to seek advice from professionals in a specific career field during a 90-minute small-group videoconference. This opportunity is designed for individuals who are entering the job market within the next 6 months. Topics of conversation will be driven by pre-submitted questions, likely related to the application process, required skills for success within that career, and culture within different types of companies. To maintain an intimate group interaction, only 6 trainees will be selected for mentor groups.
Application materials will include: your resume, a short bio statement, and three questions that you would like to explore during the mentor meeting. Submit your materials HERE.
John Barrett, PhD
Vice President, Equity Research at SVB Leerink
Dr. John Barrett joined SVB Leerink in March 2017 as an Equity Research Associate. John works on the Emerging Oncology therapeutics team covering early stage small/mid-cap biotechnology companies. John earned his Ph.D. in Molecular Engineering from the University of Chicago and his B.S. in Biomedical Engineering from Boston University.
Chieze Ibeneche-Nnewihe, PhD
Venture Associate, RA Capital Management LLC (recent)
Dr. Chieze Ibeneche-Nnewihe was a recent member of RA Capital Management’s investment team where she focused on early-stage venture investments and company creation. Prior to this role, Chieze was a Senior Associate within RA Capital’s TechAtlas research division responsible for developing competitive landscapes in the rare disease space. Chieze holds a BS and a PhD in Physics from the University of Texas at Austin. Her doctoral research in biophysics focused on the physical changes cells undergo as a result of external stress. Chieze is currently transitioning to an operating role within the biotech ecosystem.
Michael Burrows, PhD
Vice President, Life Sciences, Aspire Capital Partners, LLC
Prior to joining Aspire Capital, Dr. Burrows was a biomedical researcher at the University of Chicago where his work focused on better understanding the relationship between autoimmune disease and the microbiota. He has developed expertise in a number of disease models and his research has resulted in several publications in high impact journals including Immunity and Proceedings of the National Academy of Sciences. Additionally, Dr. Burrows gained significant experience in the technological and commercial assessment of early stage biotechnology projects while serving as a Chicago Innovation Mentors Fellow and a CIE Innovation Fund Associate. Previously, he worked as a research scientist for an immunotherapeutics company where he was responsible for drug development. Dr. Burrows received a Ph.D. in Immunology at the University of Chicago, an M.S. in Microbiology from the University of Nebraska Medical Center, and a B.S. in Microbiology from the University of Illinois Urbana-Champaign.